Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does terbutaline damage the developing heart?

Melissa C Rhodes1, Abraham Nyska, Frederic J Seidler

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|January 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and performance of vibration-assisted extraction of chronic cardiac implantable electronic device leads: A pre-clinical ovine study.

Heart rhythm·2026
Same author

Clinical and Histopathological Evaluation of Maximal and Supramaximal Energy Direct Selective Laser Trabeculoplasty (DSLT): A Rabbit Model Safety Study.

Lasers in surgery and medicine·2026
Same author

Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar rats.

Chemico-biological interactions·2026
Same author

Non-invasive quantification of viability in liver spheroids using deep learning.

Frontiers in bioengineering and biotechnology·2026
Same author

Juvenile toxicity and developmental safety of Zintrodiazine, a novel antimalarial candidate, in Wistar rats.

The Journal of antimicrobial chemotherapy·2026
Same author

Preclinical Safety Evaluation of BB106, a Novel Ketamine-Sulfobutylether-Beta-Cyclodextrin Salt, Following Subcutaneous Administration in Rats and Göttingen Minipigs.

International journal of toxicology·2026

Terbutaline, used to stop preterm labor, did not cause heart damage in developing rats. However, it may increase susceptibility to other cardiac issues in females.

Area of Science:

  • Cardiology
  • Neonatal Research
  • Pharmacology

Background:

  • Beta(2)-adrenoceptor (betaAR) agonists like terbutaline are used to halt preterm labor.
  • These drugs cross the placenta, affecting fetal tissues that rely on betaAR for growth and development.

Purpose of the Study:

  • To investigate the potential cardiac effects of postnatal terbutaline exposure in developing rats.
  • To assess whether terbutaline administration during critical developmental periods leads to cardiac abnormalities.

Main Methods:

  • Terbutaline was administered daily to rat pups during two distinct postnatal periods (Days 2-5 or 11-14).
  • Cardiac tissue was examined for damage and abnormalities 24 hours after the final dose and on postnatal day 30.

Main Results:

Related Experiment Videos

  • Neither terbutaline exposure regimen resulted in increased cardiac abnormalities compared to control groups.
  • Quantitative analysis revealed a reduction in the number of nuclei in female rat hearts post-treatment.

Conclusions:

  • The study findings do not corroborate earlier reports of myocardial necrosis in human infants treated with terbutaline.
  • A potential link between terbutaline and cardiac anomalies suggests it may sensitize the developing heart to other detrimental factors.